Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.42 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.42 |
| ▸ | LTK | P29376 | 1/20 | 0.42 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.42 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.42 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.42 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17339888 | 0.86 | ALDH1A1 (0.34) | CHEK1DAPK3LTKMAPK8CSNK1A1 | |
| SCHEMBL13183624 | 0.79 | METAP1 (0.43) | ADORA1ALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL14443260 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MAPTHPGDSMN1; SMN2KDM4E | |
| SCHEMBL14864794 | 0.79 | ADORA1 (0.50) | ADORA1ALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL23568680 | 0.77 | CHEK1 (0.42) | CHEK1DAPK3LTKMAPK8CSNK1A1 | |
| SCHEMBL5731723 | 0.74 | AHR (0.45) | LTKCDK8CDK5LRRK2DYRK1B | |
| SCHEMBL13183706 | 0.74 | LMNA (0.42) | ADORA1HPGDSMN1; SMN2NPC1LMNA | |
| SCHEMBL4493741 | 0.74 | ALDH1A1 (0.34) | ADORA1ALDH1A1HPGDNPC1RAB9A | |
| SCHEMBL15274291 | 0.73 | MAOA (0.42) | CHEK1DAPK3LTKMAPK8CSNK1A1 | |
| SCHEMBL4500371 | 0.72 | PNMT (0.40) | ALDH1A1RAB9APNMTTSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9312501-B2 | Semiconducting compounds and optoelectronic devices incorporating same | POLYERA CORPORATION (US) | 2016-04-12 | — | — | US | disclosed |
| US-8883958-B2 | Conjugated polymers and their use in optoelectronic devices | RAYNERGY TEK INC. (TW) | 2014-11-11 | — | — | US | disclosed |
| US-8841409-B2 | Conjugated polymers and their use in optoelectronic devices | POLYERA CORPORATION (US) | 2014-09-23 | — | — | US | disclosed |
| US-8835598-B2 | Conjugated polymers and their use in optoelectronic devices | POLYERA CORPORATION (US) | 2014-09-16 | — | — | US | disclosed |
| US-20130248831-A1 | Conjugated Polymers and Their Use in Optoelectronic Devices | POLYERA CORPORATION (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130247991-A1 | Conjugated Polymers and Their Use in Optoelectronic Devices | RAYNERGY TEK INC. (TW) | 2013-09-26 | — | — | US | disclosed |
| US-20130247990-A1 | Conjugated Polymers and Their Use in Optoelectronic Devices | RAYNERGY TEK INC. (TW) | 2013-09-26 | — | — | US | disclosed |
| US-20100222601-A1 | SYNTHESIS OF CYCLOPENTADIENE DERIVATIVES | BASELL POLYOLEFINE GMBH (DE) | 2010-09-02 | — | — | US | disclosed |
| US-20100222601-A1 | SYNTHESIS OF CYCLOPENTADIENE DERIVATIVES | BASELL POLYOLEFINE GMBH (DE) | 2010-09-02 | — | — | US | disclosed |
| US-7635781-B2 | Synthesis of cyclopentadiene derivatives | BASELL POLYOLEFINE GMBH (DE) | 2009-12-22 | — | — | US | disclosed |
| US-20080287692-A1 | Synthesis of cyclopentadiene derivatives | BASELL POLYOLEFINE GMBH (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080287692-A1 | Synthesis of cyclopentadiene derivatives | BASELL POLYOLEFINE GMBH (DE) | 2008-11-20 | — | — | US | disclosed |
| EP-1387827-B1 | SYNTHESIS OF CYCLOPENTADIENE DERIVATIVES | BASELL POLYOLEFINE GMBH (DE) | 2008-09-24 | — | — | EP | disclosed |
| EP-1387827-B1 | SYNTHESIS OF CYCLOPENTADIENE DERIVATIVES | BASELL POLYOLEFINE GMBH (DE) | 2008-09-24 | — | — | EP | disclosed |
| US-7253292-B2 | Synthesis of cyclopentadiene derivatives | BASELL POLYOLEFINE GMBH (DE) | 2007-08-07 | — | — | US | disclosed |
| US-7253292-B2 | Synthesis of cyclopentadiene derivatives | BASELL POLYOLEFINE GMBH (DE) | 2007-08-07 | — | — | US | disclosed |
| US-7253292-B2 | Synthesis of cyclopentadiene derivatives | BASELL POLYOLEFINE GMBH (DE) | 2007-08-07 | — | — | US | disclosed |
| US-20040236115-A1 | Synthesis of cyclopentadiene derivatives | EQUISTAR CHEMICALS, LP | 2004-11-25 | — | — | US | disclosed |
| EP-1387827-A2 | SYNTHESIS OF CYCLOPENTADIENE DERIVATIVES | Basell Polyolefine GmbH (DE) | 2004-02-11 | — | — | EP | disclosed |
| WO-2002092564-A2 | SYNTHESIS OF CYCLOPENTADIENE DERIVATIVES | BASELL POLYOLEFINE GMBH (DE) | 2002-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040236115-A1 | Synthesis of cyclopentadiene derivatives | CYCS, DHPS, CBR1 | CHEK1 474/4885DAPK3 948/4885LTK 4517/4885 |
| US-20080287692-A1 | Synthesis of cyclopentadiene derivatives | CYCS, CYC1, CBR1 | CHEK1 1434/4885DAPK3 3398/4885LTK 3945/4885 |
| US-20100222601-A1 | SYNTHESIS OF CYCLOPENTADIENE DERIVATIVES | H1-3, H1-0, RTN3 | CHEK1 1446/4885DAPK3 1214/4885LTK 2956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.